BridgeMD
New treatment option for Neonatal Complication
Official title Can the Use of a Next Generation Partograph Improve Neonatal Outcomes? (PICRINO)
ClinicalTrials.gov ID: NCT05560802
What this study is testing
- What it's testing
- The overall aim is to evaluate the impact of the use of two different guidelines for monitoring labor progress, the WHOs LCG versus standard care, on neonatal and maternal outcomes. The hypothesis is that the use of LCG will reduce adverse neonatal outcomes and decrease the number of intrapartum Cesarean sections compared with standard care.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- -All women in active labor
You likely can't join if
- -No exclusion criteria
The study team makes the final eligibility decision.
Where it's taking place
- Eksjö, Sweden
- Falun, Sweden
- Gällivare, Sweden
- Gothenburg, Sweden
- Helsingborg, Sweden
- Huddinge, Sweden
- Hudiksvall, Sweden
- Jönköping, Sweden
- Kalmar, Sweden
- Kristianstad, Sweden
- Linköping, Sweden
- Lund, Sweden
- Skellefteå, Sweden
- Södertälje, Sweden
- Södra Sunderbyn, Sweden
- Stockholm, Sweden
- Umeå, Sweden
- Uppsala, Sweden
- Värnamo, Sweden
- Västervik, Sweden
+ 3 more site(s).
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Eksjö, Sweden; Falun, Sweden; Gällivare, Sweden; Gothenburg, Sweden; Helsingborg, Sweden; Huddinge, Sweden and 17 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.